View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Noble Life Sciences

Streptozotocin Induced Diabetic Rat Model

Free White Paper

Streptozotocin Induced Diabetic Rat Model

By Noble Life Sciences

Streptozotocin Induced Diabetic Rat Model

By Noble Life Sciences
Enter your details to receive the free paper:

Type 1 diabetes is an autoimmune disorder that affects nearly 347 million people worldwide.

The autoimmune disorder is characterised by the destruction of insulin-producing beta cells in the pancreas by the patient’s immune system. Because insulin regulates the metabolism of glucose, its absence results in dangerously elevated glucose levels in the blood.

Patients are dependent on insulin injections to regulate their blood glucose level, which must be constantly monitored throughout the day to avoid hypo or hyperglycemia. Even with careful management, Type 1 diabetes patients face the constant risk of the disease’s serious side effects, which include kidney failure, blindness, nerve damage, heart attack, stroke, and pregnancy complications.

Noble Life Sciences has optimised a streptozotocin (STZ) induced rat model of diabetes. This is the model of choice for preclinical development of therapeutic agents for diabetes.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network